Insufficient scRNA-seq data for expression of POMC at single-cell level.
Insufficient scRNA-seq data for expression of POMC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 94% | 410.52 | 2482 / 2642 | 82% | 2.16 | 578 / 705 |
adrenal gland | 100% | 770.77 | 258 / 258 | 75% | 26.99 | 173 / 230 |
pancreas | 98% | 541.61 | 323 / 328 | 74% | 3.58 | 131 / 178 |
thymus | 97% | 448.47 | 632 / 653 | 69% | 5.88 | 418 / 605 |
ovary | 95% | 206.36 | 171 / 180 | 55% | 4.94 | 235 / 430 |
lung | 78% | 158.96 | 451 / 578 | 65% | 8.31 | 745 / 1155 |
uterus | 81% | 161.71 | 138 / 170 | 59% | 9.92 | 271 / 459 |
skin | 81% | 737.17 | 1472 / 1809 | 58% | 6.36 | 276 / 472 |
prostate | 93% | 242.49 | 227 / 245 | 46% | 1.19 | 232 / 502 |
kidney | 84% | 176.29 | 75 / 89 | 54% | 1.28 | 487 / 901 |
esophagus | 89% | 399.66 | 1280 / 1445 | 48% | 7.30 | 87 / 183 |
bladder | 90% | 112.57 | 19 / 21 | 40% | 1.99 | 201 / 504 |
intestine | 91% | 253.41 | 880 / 966 | 28% | 1.06 | 147 / 527 |
stomach | 79% | 898.36 | 284 / 359 | 40% | 1.60 | 114 / 286 |
breast | 82% | 158.24 | 378 / 459 | 35% | 1.71 | 396 / 1118 |
spleen | 100% | 484.25 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 294.47 | 834 / 861 | 0% | 0 | 0 / 0 |
adipose | 89% | 230.68 | 1069 / 1204 | 0% | 0 | 0 / 0 |
liver | 65% | 240.45 | 147 / 226 | 19% | 0.51 | 77 / 406 |
lymph node | 0% | 0 | 0 / 0 | 83% | 11.56 | 24 / 29 |
peripheral blood | 77% | 203.23 | 719 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 10.28 | 34 / 45 |
muscle | 70% | 136.10 | 559 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 58% | 158.44 | 773 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 5.44 | 46 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070873 | Biological process | regulation of glycogen metabolic process |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0007165 | Biological process | signal transduction |
GO_0008217 | Biological process | regulation of blood pressure |
GO_2000852 | Biological process | regulation of corticosterone secretion |
GO_0032098 | Biological process | regulation of appetite |
GO_0007267 | Biological process | cell-cell signaling |
GO_1990680 | Biological process | response to melanocyte-stimulating hormone |
GO_0033059 | Biological process | cellular pigmentation |
GO_0140668 | Biological process | positive regulation of oxytocin production |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0106071 | Biological process | positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0042593 | Biological process | glucose homeostasis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005737 | Cellular component | cytoplasm |
GO_0030141 | Cellular component | secretory granule |
GO_0070996 | Molecular function | type 1 melanocortin receptor binding |
GO_0031781 | Molecular function | type 3 melanocortin receptor binding |
GO_0005179 | Molecular function | hormone activity |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
GO_0031782 | Molecular function | type 4 melanocortin receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | POMC |
Protein name | Pro-opiomelanocortin (POMC) (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone) (ACTH); Melanocyte-stimulating hormone alpha (Alpha-MSH) (Melanotropin alpha); Corticotropin-like intermediary peptide (CLIP); Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanocyte-stimulating hormone beta (Beta-MSH) (Melanotropin beta); Beta-endorphin; Met-enkephalin] Proopiomelanocortin Pro-opiomelanocortin Pro-opiomelanocortin (Corticotropin-lipotropin) |
Synonyms | proopiomelanocortin/ |
Description | FUNCTION: [Corticotropin]: Stimulates the adrenal glands to release cortisol.; FUNCTION: [Melanocyte-stimulating hormone alpha]: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes.; FUNCTION: [Melanocyte-stimulating hormone beta]: Increases the pigmentation of skin by increasing melanin production in melanocytes.; FUNCTION: [Beta-endorphin]: Endogenous orexigenic opiate.; FUNCTION: [Met-enkephalin]: Endogenous opiate. FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . FUNCTION: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. .; FUNCTION: Endogenous opiate. .; FUNCTION: Endogenous orexigenic opiate. .; FUNCTION: Stimulates the adrenal glands to release cortisol. . |
Accessions | K7QX47 K7RMD8 K7R8V7 ENST00000449220.1 K7QX44 K7RME8 ENST00000395826.7 K7R8V2 K7QZC2 K7QZC9 Q6FHC8 Q53WY7 ENST00000380794.5 K7R8W0 Q6LDP0 P01189 E9PHK5 K7R2J5 ENST00000405623.5 K7R2I7 K7RMF2 K7QX41 ENST00000264708.7 K7QZD2 K7QX51 |